SOFIA (Bulgaria), May 8 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday its sales revenue fell by 3.0% on the year in the first four months of 2013.
Exports decreased by an annual 6.0% through April, while sales revenue on the domestic market went up by 4.0% on the year, Sopharma said in a statement filed to the Bulgarian Stock Exchange (BSE).
In April alone, Sopharma's sales revenue remained flat year-on-year. Sales in Bulgaria rose by an annual 3.0%, while exports dropped by 1.0%.
Blue-chip Sopharma was trading flat at 2.65 levs ($1.78/1.35 euro) by 1554 CET.
(1 euro = 1.95583 Bulgarian levs)